trasylol

trasylol

美 　英

• n.抑肽酶
• 网络特雷西洛；抑肽酶特斯乐；停售特雷西洛

英汉解释

n.

1. 抑肽酶

例句

The study was the latest in a series of worrisome signs that Trasylol, also known as aprotinin, could be dangerous.

最近一系列令人担忧的迹象表明特雷西洛（又称抑肽酶）具有潜在危险性，加拿大的研究正是与此有关的一项最新结果。

Their worse outcomes would be explained not by problems with Trasylol but by their own illness.

他们较差的结果可能归因于本身的疾病而不是特拉西罗。

In September, the drug agency reconvened the expert panel, and it again voted that Trasylol should continue to be sold.

今年9月，FDA年夜头召开专家小组会议，并再次投票抉择特雷西洛是否可以继续发卖。

Trasylol's history demonstrates that once a drug is approved, halting its sale is exceedingly difficult.

特雷西洛的历史证明，一旦某种药物获得批准，要想停止其销售，那是是极其困难的。

It concluded that the patients given Trasylol were at greater risk.

得出结论是，使用特拉西罗的患者承受的风险更大。

Doctors give Trasylol to patients before surgery to reduce the risks of blood loss.

医生在开刀前给患者使用该药来减少出血的风险。

Trasylol, also known as aprotinin, has been on the market for 13 years.

又名为抑肽酶的特拉西罗，已经上市13年。

Still, the advisory panel concluded that Trasylol's risks were worth taking in some patients. Dr.

但是，咨询委员会总结认为某些病例是值得冒一下特拉西罗的风险的。

OBJECTIVE: To discuss the prevention and cure of anaphylactic shock caused by trasylol.

目的：探讨抑肽酶致过敏性休克的防治。

It examined hospital records of 67, 000 patients, 30, 000 of whom received Trasylol. The rest got other drugs.

研究回顾了67,000例病人的住院记录，其中30,000例接受了特拉西罗，剩下的则使用了其他药物。